2025-08-03 - Analysis Report
Okay, here's an analysis of Albemarle Corp (ALB) based on the data you provided.

**Report on Albemarle Corp (ALB)**

**1. Performance vs. S&P 500 (VOO)**

*   **Ticker:** ALB
*   **Company Name:** Albemarle Corp
*   **Company Overview:** Albemarle Corp is a specialty chemicals company with leading positions in lithium, bromine specialties, and catalysts.
*   **ALB Cumulative Return:** -7.64%
*   **VOO (S&P 500) Cumulative Return:** 94.15%
*   **Disparity:**
    *   **Current Disparity:** -90.9
    *   **Disparity Range:** Max 215.1, Min -97.5
    *   **Relative Disparity:** 2.1

**Analysis:** ALB has significantly underperformed the S&P 500. The relative disparity indicates that ALB's current underperformance is near the lower end of its historical range relative to the S&P 500.  The significant negative cumulative return suggests substantial challenges or negative sentiment surrounding the stock.

**Alpha/Beta Analysis:**

| Year       | CAGR   | MDD   | Alpha   | Beta  | Cap(B) |
|------------|--------|-------|---------|-------|--------|
| 2015-2017  | -4.0%  | 0.0%  | -33.0%  | 15.5  | 15.1   |
| 2016-2018  | -31.0% | 57.3% | -49.0%  | -0.1  | 9.1    |
| 2017-2019  | -26.0% | 57.3% | -56.0%  | -0.2  | 8.6    |
| 2018-2020  | 104.0% | 62.7% | 85.0%   | -0.1  | 17.4   |
| 2019-2021  | 214.0% | 62.7% | 166.0%  | -0.1  | 27.5   |
| 2020-2022  | 187.0% | 75.6% | 185.0%  | -0.1  | 25.5   |
| 2021-2023  | -32.0% | 77.5% | -50.0%  | 0.7   | 17.0   |
| 2022-2024  | -145.0%| 77.5% | -171.0% | 1.2   | 10.1   |
| 2023-2025  | -248.0%| 77.5% | -294.0% | 0.6   | 8.0    |

**Analysis:**

*   **CAGR & MDD:**  The CAGR (Compound Annual Growth Rate) is highly volatile, with periods of significant growth followed by substantial declines. The MDD (Maximum Drawdown) is consistently high, indicating significant risk.
*   **Alpha:**  The consistently negative and very large alpha values suggest ALB has significantly underperformed its benchmark even after accounting for market risk.
*   **Beta:**  Beta values fluctuate, but are generally around 0, suggesting ALB's price is not highly correlated with the broader market. Recent Beta values (0.6 and 1.2) indicate slightly increased market sensitivity compared to earlier periods.
*   **Cap(B):** The Market Capitalization has been declining over the last few years, which could be a cause for concern.

**2. Recent Price Action**

*   **Current Price:** $67.90
*   **Last Market Data:** price: 67.9, previousClose: 67.85, change: 0.07
*   **5-Day Moving Average:** 70.20
*   **20-Day Moving Average:** 73.76
*   **60-Day Moving Average:** 64.70

**Analysis:**

*   The price is slightly up from the previous close.
*   The price is below the 5-day and 20-day moving averages, suggesting a short-term downtrend. However, it's above the 60-day moving average, indicating a possible longer-term uptrend, but the moving averages are converging, which could signal a shift.
*  Given the small change from the previous close, there are no significant price action issues to report.

**3. Technical Indicators and Expected Return**

*   **Market Risk Indicator (MRI):** 0.3358 (Low Risk)
*   **RSI:** 45.19
*   **PPO:** -2.27
*   **Hybrid Signal:** Cash_70%_Sell (70% holdings)
*   **Recent (20-Day) Relative Disparity Change:** -5.6 (downward trend)
*   **Expected Return:** 3055.8%

**Analysis:**

*   **MRI:** The MRI indicates low market risk.
*   **RSI:** The RSI is near the neutral level (50), suggesting neither overbought nor oversold conditions.
*   **PPO:** A negative PPO indicates that the short-term moving average is below the long-term moving average, confirming the recent downtrend.
*   **Hybrid Signal:** The hybrid signal suggests selling 70% of holdings, likely driven by the observed technical indicators and risk assessment.
*   **Relative Disparity Change:** The negative change in relative disparity indicates a recent worsening of ALB's performance relative to its benchmark.
*   **Expected Return:** The extremely high expected return suggests a potentially undervalued stock with significant long-term growth potential. However, this figure should be viewed with caution, as it may be based on optimistic assumptions or specific models that don't fully reflect current market conditions.

**4. Recent News & Significant Events**

*   **2025-08-02:** Major business developments, regulatory changes, or market events impacting ALB.
*   **2025-07-31:** Analysts discussing ALB's recent performance and outlook.
*   **2025-08-01:** Stock volatility influenced by recent news, earnings reports, or executive actions.
*   **2025-07-30:** Experts highlighting risks and opportunities for ALB.

**Analysis:**  Recent news indicates significant developments and volatility surrounding ALB, requiring close monitoring of company announcements and market conditions.

**5. Recent Earnings Analysis**

| 날짜       | EPS   | 매출        |
|------------|-------|-------------|
| 2025-04-30 | 0     | 1.08 B$     |
| 2024-11-06 | -9.45 | 1.35 B$     |
| 2024-07-31 | -1.96 | 1.43 B$     |
| 2024-05-01 | -0.08 | 1.36 B$     |
| 2025-04-30 | -0.08 | 1.36 B$     |

**Analysis:**

*   **EPS Trend:** ALB's EPS has been volatile, with significant losses in recent quarters. The most recent EPS is slightly positive, but it doesn't offset the previous losses.
*   **Revenue Trend:** Revenue has been declining over the recent quarters. The combination of declining revenue and negative EPS is a cause for concern.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue | Profit Margin |
|--------------|---------|---------------|
| 2025-03-31   | $1.08B  | 14.51%        |
| 2024-12-31   | $1.23B  | 11.22%        |
| 2024-09-30   | $1.35B  | -7.68%        |
| 2024-06-30   | $1.43B  | -0.74%        |
| 2024-03-31   | $1.36B  | 2.86%         |

**Capital and Profitability:**

| Quarter      | Equity  | ROE     |
|--------------|---------|---------|
| 2025-03-31   | $10.03B | 0.41%   |
| 2024-12-31   | $9.96B  | 0.76%   |
| 2024-09-30   | $10.24B | -10.44% |
| 2024-06-30   | $11.22B | -1.68%  |
| 2024-03-31   | $11.53B | 0.02%   |

**Analysis:**

*   **Revenue & Profit Margin:** Revenue has decreased from the first to the last quarter, and the profit margin has fluctuated significantly, turning negative in some quarters. This indicates potential issues with cost management or decreased demand.
*   **Equity & ROE:** The equity has decreased over the quarters, suggesting that the company's financial health may be deteriorating. The negative ROE (Return on Equity) in some quarters confirms this, as it indicates that the company is not effectively generating profits from its equity.

**7. 종합 Analysis (Overall Summary)**

Albemarle Corp (ALB) is currently facing significant challenges. It has substantially underperformed the S&P 500, with a large negative cumulative return and a recent decline in performance relative to its benchmark.  The company's earnings have been weak, with declining revenue, negative EPS, and fluctuating profit margins.  Financial health concerns are raised by decreasing equity and negative ROE.

Technically, the stock is in a short-term downtrend, and the hybrid signal suggests reducing holdings. While the MRI indicates low market risk, the overall picture suggests caution. The extremely high expected return is intriguing but should be viewed with skepticism until the company demonstrates a clear turnaround. Recent news and events highlight volatility and uncertainty surrounding the stock.

**Recommendation:**  Given the current financial performance, technical indicators, and market sentiment, a cautious approach is warranted. Further investigation into the reasons behind the underperformance and the company's plans for improvement is recommended before making any investment decisions. The extremely high expected return warrants further scrutiny to determine its validity.
